Stocks and InvestingStocks and Investing
Fri, August 11, 2023
Thu, August 10, 2023

Serge Belanger Maintained (VRDN) at Strong Buy with Decreased Target to $40 on, Aug 10th, 2023


Published on 2024-10-28 05:48:40 - WOPRAI, Serge Belanger
  Print publication without navigation


Serge Belanger of Needham, Maintained "Viridian Therapeutics, Inc." (VRDN) at Strong Buy with Decreased Target from $47 to $40 on, Aug 10th, 2023.

Serge has made no other calls on VRDN in the last 4 months.



There are 6 other peers that have a rating on VRDN. Out of the 6 peers that are also analyzing VRDN, 0 agree with Serge's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Serge


  • Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $44 on, Wednesday, August 9th, 2023
  • Jason Butler of "JMP Securities" Maintained at Buy with Decreased Target to $42 on, Wednesday, August 9th, 2023
  • Leland Gershell of "Oppenheimer" Maintained at Buy with Decreased Target to $35 on, Wednesday, August 9th, 2023
  • Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $45 on, Tuesday, July 11th, 2023
  • Tiago Fauth of "Credit Suisse" Initiated at Buy and Held Target at $51 on, Wednesday, June 14th, 2023
  • Julian Harrison of "BTIG" Initiated at Strong Buy and Held Target at $46 on, Wednesday, June 14th, 2023